Novo Nordisk Faces Board Overhaul Amid Strategic Shifts and Market Pressures
Leadership Turmoil at Europe’s Former Most Valuable Company Novo Nordisk, the Danish pharmaceutical giant behind blockbuster drugs Ozempic and Wegovy,…
Leadership Turmoil at Europe’s Former Most Valuable Company Novo Nordisk, the Danish pharmaceutical giant behind blockbuster drugs Ozempic and Wegovy,…